ERBB2 and breast carcinoma: Breast cancer consists of four major molecular subtypes: luminal A (Hormone receptor (HR)+/HER2), luminal B (HR+/HER2+), HER2-enriched (HR−/HER2+) and triple-negative or basal-like (HR−/HER2−) [11,12,13].